硕士生导师

吕燕妮

姓名:吕燕妮

职称:副主任药师

邮箱:lvyanni@126.com

籍贯:江西南昌

导师类型:硕士生导师

主讲课程:临床药物治疗学

个人主页:

研究方向

中药心脑血管药理;脑缺血后血管内皮损伤;药品临床综合评价

教育经历

2003.9~2007.6:江西中医药大学,药学专业,理学学士

2007.9~2010.6:中国药科大学,药物分析,理学硕士

2010.9~2013.6:中国药科大学,中西医结合基础药学,理学博士

工作履历

2013.6~至今:南昌大学第一附属医院,副主任药师,临床药学科科长

2016.4~2017.4:江西省人民医院进修临床药师(神经内科专业

学术兼职

 世界中医药联合会网络药理学专业委员会委员

 中国药学会罕见病药物专委会委员

 江西省药学会药事管理专业委员会副主任委员

 江西省妇幼保健与优生优育协会药事管理专业委员会副主任委员

 江西省中西医结合学会循证医学分会副主任委员

 江西省中西医结合学会临床药学分会常务委员

 江西省卒中学会理事

 江西省转化医学会理事

个人荣誉

 聘任为《药品评价》杂志编委

 聘任为《国际中医中药杂志》杂志编委

主要业绩

主要科研成果

主持国家自然科学基金青年和地区课题2项,主持江西省自然科学基金重点项目、面上项目、青年项目3项。第一或通讯作者在国内外权威刊物发表学术论文30余篇,其中SCI收录论文15余篇。获第二届江西省医学科技奖医学科技青年创新奖(1/5),并受邀中华医学会临床药学分会全国学术会议大会发言2次,获中国脑卒中大会论文征文优秀奖和北斗奖等。

1、 主持科研课题

[1] 国家自然科学基金青年项目,LRG1调控脂质代谢重编程介导脑缺血后血管内皮紧密连接损伤的机制研究(82100417),2022/01-2024/12,30万,主持

[2] 国家自然科学基金地区项目,循环微囊泡miR-20a跨细胞通讯参与缺血后脑血管内皮损伤的机制研究(81760094),2018/01-2021/12,34万,主持

[3] 江西省自然科学基金面上项目,20212BAB206022,非肌肉肌球蛋白重链ⅡA调控脑缺血后小胶质细胞外泌体释放及对血管内皮细胞加权基因共表达网络的调控,2022/01-2024/12,10万,主持

[4] 江西省自然科学基金面上重点项目,20202ACBL206001,拟缺血条件下miR-20a/NMMHC ⅡA调控脂筏参与血管内皮细胞异常荷脂的初步机制研究,2021/01-2023/12,20万,主持

[5] 江西省自然科学基金青年基金一般项目,20171BAB215021,羟基红花黄色素A对脑缺血再灌注后外泌体miR-27a跨细胞介导血脑屏障损伤调控机制的初步研究, 2017/07-2019/12,10万,主持

2、发表代表性论文

1)Zhaohui Ruan, Guosheng Cao, Yisong Qian, Longsheng Fu, Jinfang Hu, Tiantian Xu, Yaoqi Wu, Yanni Lv(*). Single-Cell RNA Sequencing Unveils Lrg1's Role in Cerebral Ischemia‒Reperfusion Injury by Modulating Various Cells. Journal of Neuroinflammation. 2023. DOI: 10.1186/s12974-023-02941-4.

2)Fu L, Zou Y, Yu B, Hong D, Guan T, Hu J, Xu Y, Wu Y, Kou J(*), Lv Y(*). Background and roles: myosin in autoimmune diseases. Frontiers in Cell and Developmental Biology. 2023, 11: 1220672.

3)Longsheng Fu, Jinfang Hu, Feng Shao, Yaoqi Wu, Wer Bai, Mmingjin Jiang, Hao Chen, Lihua Chen, Yanni Lv(*). Biochanin A, as the Lrg1/TGF-β/smad2 pathway blockade, attenuates blood-brain barrier damage after cerebral ischemia-reperfusion by modulating leukocyte migration patterns. 2023. Biocell. 2023 47(8): 1869-1883.

4)Jinfang Fu, Jiangen Ao, Longsheng Fu, Yaoqi Wu, Feng Shao, Tiantian Xu, Mingjin Jian, Sshaofeng Xiong, Yanni Lv(*). Exploring the attenuation mechanisms of Dalbergia odorifera leaves extract on cerebral ischemia-reperfusion based on weighted gene co-expression network analysis. Biocell. 2023, 47(7): 1611-1622.

5)Zhiqiang Lei, Xiang Hu, Yaoqi Wu, Longsheng Fu, Songqing Lai, Jing Lin, Xiaobing Li, Yanni Lv(*). The Role and Mechanism of the Vascular Endothelial Niche in Diseases: A Review. Front Physiol. 2022, 13: 863265.

6)Yonghui Zou, Yi Xu, Xiaofeng Chen, Yaoqi Wu, Longsheng Fu, Yanni Lv(*). Research Progress on Leucine-rich Alpha-2 glycoprotein 1: A Review. Frontiers in Pharmacology. 2022, 12: 809225.

7)Yanni Lv(*), Daojun Hong, Longsheng Fu1 Yisong Qian. NMMHC IIA triggered lipid metabolize reprogramming resulting in vascular endothelial cellular tight junction injury. Molecular Biology Reports. 2022 , 49(4): 2805-2819.

8)Yanni Lv, Xuehan Wu, Jin Chen, Feng Shao(*). Ruscogenin attenuated tight junction injury and tumor migration in colorectal liver metastasis mice via regulating TRAP1. Translational Cancer Research. 2021, 10(3): 1470-1483.

9)Yanni Lv, Jin Chen(*), Jinfang Hu, Yisong Qian, Ying Kong, Longsheng Fu. Nonmuscle Myosin Heavy Chain ⅡA-Mediated Exosome Release via Regulation of the Rho-Associated Kinase 1/Myosin Light Chains/Actin Pathway. Frontiers in Pharmacology. 2020, 11: 598592.

10)Zhaohui Ruan#, Zixuan Xu#, Zhaozhi Li, Yanni Lv(*). Integral analyses of survival-related long non-coding RNA MIR210HG and its prognostic role in colon cancer. Oncology Letters. 2019, 18: 1107-1116.

11)Quan M, Lv Y, Dai Y, Qi B, Fu L, Chen X, Qian Y(*). Tanshinone IIA protects against lipopolysaccharide-induced lung injury through targeting Sirt1. J Pharm Pharmacol. 2019, 71(7): 1142-1151.

12)Lv Y(*), Liu W, Ruan Z, Xu Z, Fu L. Myosin IIA regulated tight junction in oxygen glucose deprivated brain endothelial cells via activation of TLR4/PI3K/Akt/JNK1/2/14-3-3ε/NF-κB/MMP9 signal transduction pathway. Cellular and Molecular Neurobiology. 2019, 39(2): 301-319.

13)Lv Y(*), Fu L. The potential mechanism for Hydroxysafflor yellow A attenuating blood-brain barrier dysfunction via tight junction signaling pathways excavated by an integrated serial affinity chromatography and shotgun proteomics analysis approach. Neurochem Int. 2018, 112, 38-48.

14)Lv Y(*), Ou-Yang A, Fu L. MicroRNA-27a Negatively Modulates the Inflammatory Response in Lipopolysaccharide-Stimulated Microglia by Targeting TLR4 and IRAK4. Cell Mol Neurobiol. 2017, 37(2), 195-210.

15)Lv Y(*), Qian Y, Ou-Yang A, Fu L. Hydroxysafflor Yellow A Attenuates Neuron Damage by Suppressing the Lipopolysaccharide-Induced TLR4 Pathway in Activated Microglial Cells. Cell Mol Neurobiol. 2016, 36(8), 1241-1256.

3、成果获奖:

[1] 脑缺血后炎症反应损伤的分子机制及干预研究, 2022年第二届江西省医学科技奖医学科技青年创新奖, 2023年6月, 江西南昌, 吕燕妮(1/5)

[2] 檀脂清-降香黄檀的创新性开发. 第十三届“创青春·挑战杯”南昌大学大学生创业计划项目院级二等奖. 吕燕妮(第一指导老师).

[3] 檀密钙-降香黄檀叶提取物口服溶液. 第八届南昌大学“互联网+”大学生创新创业大赛高教主赛道本科生创意组三等奖. . 吕燕妮(第二指导老师).